CTIS is pleased to announce that its CEO, Mr. Raj Shah, has accepted the invitation to join the Institute of Human Virology (IHV) Board of Directors as of September 4th. Mr. Shah’s shares the same vision as IHV: to combine the disciplines of basic science, epidemiology, and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders.
The IHV, University of Maryland, School of Medicine was established to create and develop a world-class center of excellence focusing on chronic viral diseases, especially HIV/AIDS, and virally-linked cancers. The IHV is dedicated to the discovery, research, treatment, and prevention of these diseases. Its unique structure seeks to connect cohesive, multi-disciplinary research and clinical programs so that new treatments are streamlined from discovery to patient. The IHV serves patients locally and the scientific community globally.
CTIS, as a founding partner of International Spirit of Healing (ISOH), sponsors a scholarship program called ‘The Rina Shah Short-Term Exchange Program (STEP)’ to better connect the Global Virus Network (GVN) Centers. The program offers opportunities in skill-building and in developing collaborations between emerging medical virologists with the goal of maintaining and increasing their interest in medical virology as a career. This program will support travel of up to 2 weeks for post-doctoral level scientists and assistant professors in order to enhance medical virology skills or knowledge sets, or to develop collaborative research proposals.
The Global Virus Network (GVN), a non-profit organization, is a coalition of top medical virology institutions worldwide working to address all viral challenges to human health and to prepare for the emergence and potential spread of new viruses globally. GVN supports research, training, education, and advocacy in medical virology.
CTIS is pleased to announce that its CEO, Mr. Raj Shah, has been elected by The International Network for Cancer Treatment and Research (INCTR) Board of Directors as the President of the INCTR USA Branch as of Tuesday, July 23, 2013. Mr. Shah has been a long-standing member of INCTR's Brussels Board and has made important contributions to various INCTR projects.
INCTR USA supports the central mission of INCTR by developing links with cancer centers and oncologists/scientists in North America. The USA Branch has a special interest in reducing disparities in access to health care and on improving the quality of existing health services for patients living in countries or regions where health services for non-communicable diseases (NCDs) are inadequate to meet their needs, or where other barriers (cultural, financial, educational, or undefined) result in suboptimal prevention and care of NCDs in minority populations. In order to attain this, INCTR USA will primarily focus on prevention and management or cure in the USA as well as low and/or middle income countries. Please refer to the INCTR website for more details.
CTIS is proud to announce that we have been appraised at Level 3 of the CMMI Institute’s Capability Maturity Model Integration (CMMI) on July 18, 2013. This is a process improvement approach that provides organizations with essential elements of effective processes that ultimately improve their performance. Appraisal at Level 3 means that our processes are well characterized and understood; can be found in standards, procedures, tools, and methods; and are established and improved over time. Refer to the results on the Published Appraisal Results System (PARS).
The National Institute on Minority Health and Health Disparities (NIMHD), NIH has awarded a Grant Number U54MD008608 to CTIS to build a Transdisciplinary Coordination Center (TCC) as defined by The Health Policy Research Consortium (HPRC) Program. The purpose of the center, HRPC, is to close the gap in healthcare across social, ethnic, and racial groups in the DC, MD and VA area (DMV). The focus of the center is how health policies influence the access of ethnic and racial minorities to adequate and affordable healthcare. The grant award is set over a period of five years, which will allow CTIS to expand upon its commitment to reducing health disparity.
CTIS, with its motivation to leverage the power of health informatics in order to improve patient outcomes while lowering healthcare costs, has received this grant. This will allow CTIS to showcase its experience in policy knowledge, information technology, research, education, outreach, analysis, communication, process re-engineering, program management, and best practices.
CTIS is proud to announce that Mr. Dennis Roberts has joined CSGI’s Board of Directors effective February 11, 2013. Mr. Roberts, with over 35 years of experience in accounting and investment banking, is currently the Chairman of The McLean Group, LLC. He founded a publicly-held National bank holding company and also a large, local accounting firm, both of which he had held distinguished leadership positions in. A Benjamin Franklin University graduate (which later merged with George Washington University), Mr. Roberts teaches and lectures in the fields of mergers and acquisitions, business valuation, and corporate finance to national audiences.
CTIS is proud to participate as a gold sponsor for the GWAC Small Business Summit at The Hamilton Live in Washington D.C. on February 20. The Summit, which is hosted by AFCEA Bethesda, will discuss the challenges and best practices on how small businesses market and manage current GSA vehicles; emerging vehicle opportunities; teaming opportunities with large businesses; and a procurement outlook on contract vehicles in 2013, among other issues. Please visit AFCEA site for more information.
Mr. Raj Shah, CTIS Chairman and CEO, has been recently appointed to the Global Virus Network’s (GVN) Board of Directors, as announced on January 16th by Robert C. Gallo, co-founder of the GVN and Chair of GVN’s Scientific Leadership Board. GVN is a non-profit coalition of leading medical virology research centers from around the world whose mission is to combat emerging and current viral disease through international collaborative research and training.
Upon his Board appointment, Mr. Shah said “The promise and commitment of having a healthy world by eliminating health disparity can’t be achieved without building a solution that deals with virus management.” Mr. Shah is one of ten Board appointees who “will add valuable resources to the GVN and will greatly enhance GVN’s global visibility,” said Dr. Gallo, who is also the Director of the Institute of Human Virology at the University Of Maryland School Of Medicine. Read more about the GVN Board of Directors.